CClinicalTrials.gg
RecruitingNCT05363189BestDIEPUpdated Jul 3, 2025

Optimizing Postoperative Recovery After Breast Reconstruction With Autologous Tissue (BestDIEP)

An observational study in Breast Reconstruction and Breast Cancer, sponsored by Vastra Gotaland Region. Recruiting at 1 site in Sweden. Open to female participants aged 18 Years to 100 Years. Per ClinicalTrials.gov, last updated 2025-07-03.

Sponsored by Vastra Gotaland Region · Observational

From the registry’s dates

  • Started May 2022; still recruiting 4 years 5 months later.
Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
380
Ages
18 Years to 100 Years
Sex
Female
01

Study summary

Women who have their breast reconstructed with autologous tissue seem to be more satisfied with their breast. However, autologous breast reconstruction entails a bigger operation, and the usage of more health care resources, than some other methods, such as implant-based techniques. The main objectives of the present study are to investigate if pre- peri- and postoperative protocols can be safely modified, so the operation demands less resources, while maintaining a low complication rate and a high patient satisfaction.

02

Conditions studied

  • Breast Reconstruction
  • Breast Cancer

Browse trials for

Keywords

  • breast reconstruction
  • plastic surgery
  • microsurgery
  • free flap
03

In context

Breast Neoplasms

12,544 studies on the registry are indexed under Breast Neoplasms; 2,892 are open to participants now.

This study's planned enrollment of 380 is above the median of 184 across 2,642 observational studies indexed under Breast Neoplasms.

Browse Breast Neoplasms studies →

Lead sponsor

Vastra Gotaland Region is the lead sponsor of 267 studies on the registry; 107 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 100 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Biological women undergoing breast reconstruction with a deep inferior epigastric artery perforator flap in Sahlgrenska university hospital.

Inclusion criteria

  • Operated or will be operated with a DIEP flap in the department
  • >18 years of age

Exclusion criteria

Exclusion Criteria:

  • Inability to leave informed consent
  • Inability to understand and speak Swedish (for the questionnaire)
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
380 participants (estimated)
Patient registry
No

Groups and cohorts

  • No venons augmentation

    Retrospective group of patients who have not received venous augmentation during their operation.

    Procedure: No venous augmentation

  • Venous augmentation

    Retrospective group of patients who have received venous augmentation during their operation.

    Procedure: Venous augmentation

  • ERAS protocol

    Retrospective group operated according to the traditional ERAS (enhanced recovery after surgery) protocol

    Procedure: Traditional ERAS (enhanced recovery after surgery) protocol

  • Sahlgrenska recovery protocol

    Prospective group operated according to the Sahlgrenska recovery protocol.

    Procedure: Sahlgrenska recovery protocol

Interventions

  • ProcedureVenous augmentation

    Increasing the venous drainage of a deep inferior epigastric artery perforator (DIEP) flap by anastomosing the superficial inferior epigastric vein to the cephalic vein

    Also known as: Double venous system drainage, Cephalic vein turndown

  • ProcedureTraditional ERAS (enhanced recovery after surgery) protocol

    Pre-, peri-, and post-operative care as described in the ERAS protocol

  • ProcedureSahlgrenska recovery protocol

    Pre-, peri-, and post-operative care as described in the Sahlgrenska recovery protocol

  • ProcedureNo venous augmentation

    Traditional deep inferior epigastric artery perforator flap (DIEP)

06

What researchers measure

Primary outcomes

  1. Re-operations

    Any re-operations performed for any cause during the first 7 days after the operation

    Time frame: 7 days

  2. Length of stay (LOS) in hospital

    Number of days the patient stays in the hospital after the operation

    Time frame: 7 days

Secondary outcomes

  1. Patient reported satisfaction and quality of life

    Measured with BREAST-Q reconstruction. The patient scores different items om a scale and a sum score of 0-100 is calculated for each domain. A higher score indicates a higher satisfaction/quality of life.

    Time frame: 12 months

  2. Surgical corrections

    Number of cosmetic corrections. All types of corrections performed in general or local anesthetics will be included.

    Time frame: 5 years

  3. Costs

    Health economical analysis of direct and indirect cost related to the different protocols

    Time frame: 5 years

07

Study locations

1 of 1 sites recruiting
  • Sahlgrenska university hospital
    Gothenburg, 413 45, Sweden
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 3, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05363189
Lead sponsor
Vastra Gotaland Region
Responsible party
Sponsor
First posted
May 5, 2022
Start date
May 2, 2022
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Jul 3, 2025

Study contacts

Emma Hansson, MD, PhD
Contact
emma.em.hansson@vgregion.se
0046313421000

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion